Ubiquitin Proteasome System in CNS Neurodegenerative Diseases
portes grátis
Ubiquitin Proteasome System in CNS Neurodegenerative Diseases
Singh, Sarika
Springer Verlag, Singapore
02/2026
378
Dura
Inglês
9789819560981
15 a 20 dias
Descrição não disponível.
Section I: Introduction to Ubiquitin Proteasome System (UPS).- Chapter 1: Ubiquitin Proteasome System (UPS): Role in Cellular Physiology.- Chapter 2: Ubiquitin Proteasome System (UPS) and Molecular Chaperones.- Chapter 3: Ubiquitin Proteasome System (UPS) and Energy Bioenergetics.- Section II: Signaling Mechanisms in Ubiquitin Proteasome System (UPS).- Chapter 4: Protein Homeostasis and Ubiquitin Proteasome System (UPS).- Chapter 5: Neuroinflammation and Ubiquitin Proteasome System (UPS).- Chapter 6: Endoplasmic Reticulum and Ubiquitin Proteasome System (UPS).- Chapter 7: Triggers of Ubiquitin Proteasome System (UPS): Disease Aspects.- Chapter 8: Ubiquitin Signaling in Central Nervous System (CNS) Neurodegenerative Diseases.- Chapter 9: E3 Ubiquitin Ligases in Central Nervous System (CNS) Neurodegenerative Diseases.- Chapter 10: Deubiquitinating Enzymes in Central Nervous System (CNS) Neurodegenerative Disease.- Chapter 11: Proteasome Machinery in Neurodegenerative Signaling.- Section III: Therapeutic Options for Ubiquitin Proteasome System (UPS).- Chapter 12: Targeting Ubiquitin Proteasome System (UPS) by Natural Products.- Chapter 13: Inhibitors of Protein Aggregates.- Chapter 14: HDAC Inhibitors on Protein Quality Control System.- Section IV: Experimental Tools for Ubiquitin Proteasome System (UPS).- Chapter 15: Animal Models of Disease.- Chapter 16: Pros and Cons of Sporadic Versus Genetic Models of Diseases.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Mechanisms of protein degradation;Ubiquitin-proteasome Syatem (UPS) in Parkinson's diseases (PD);Ubiquitin-proteasome Syatem (UPS) in Alzheimer's diseases (AD);Alzheimer's signaling pathway;Parkinson's signaling pathway;Proteolysis in neurodegenerative diseases;E3 ubiquitin ligases in Parkinson's pathology;E3 ubiquitin ligases in Alzheimer's pathology;Ubiquitin signalling in neurodegenerative diseases;Protein homeostasis in neurodegenerative diseases;Animal models for Parkinson's disease (PD);Animal Models of Alzheimer's disease (AD)
Section I: Introduction to Ubiquitin Proteasome System (UPS).- Chapter 1: Ubiquitin Proteasome System (UPS): Role in Cellular Physiology.- Chapter 2: Ubiquitin Proteasome System (UPS) and Molecular Chaperones.- Chapter 3: Ubiquitin Proteasome System (UPS) and Energy Bioenergetics.- Section II: Signaling Mechanisms in Ubiquitin Proteasome System (UPS).- Chapter 4: Protein Homeostasis and Ubiquitin Proteasome System (UPS).- Chapter 5: Neuroinflammation and Ubiquitin Proteasome System (UPS).- Chapter 6: Endoplasmic Reticulum and Ubiquitin Proteasome System (UPS).- Chapter 7: Triggers of Ubiquitin Proteasome System (UPS): Disease Aspects.- Chapter 8: Ubiquitin Signaling in Central Nervous System (CNS) Neurodegenerative Diseases.- Chapter 9: E3 Ubiquitin Ligases in Central Nervous System (CNS) Neurodegenerative Diseases.- Chapter 10: Deubiquitinating Enzymes in Central Nervous System (CNS) Neurodegenerative Disease.- Chapter 11: Proteasome Machinery in Neurodegenerative Signaling.- Section III: Therapeutic Options for Ubiquitin Proteasome System (UPS).- Chapter 12: Targeting Ubiquitin Proteasome System (UPS) by Natural Products.- Chapter 13: Inhibitors of Protein Aggregates.- Chapter 14: HDAC Inhibitors on Protein Quality Control System.- Section IV: Experimental Tools for Ubiquitin Proteasome System (UPS).- Chapter 15: Animal Models of Disease.- Chapter 16: Pros and Cons of Sporadic Versus Genetic Models of Diseases.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Mechanisms of protein degradation;Ubiquitin-proteasome Syatem (UPS) in Parkinson's diseases (PD);Ubiquitin-proteasome Syatem (UPS) in Alzheimer's diseases (AD);Alzheimer's signaling pathway;Parkinson's signaling pathway;Proteolysis in neurodegenerative diseases;E3 ubiquitin ligases in Parkinson's pathology;E3 ubiquitin ligases in Alzheimer's pathology;Ubiquitin signalling in neurodegenerative diseases;Protein homeostasis in neurodegenerative diseases;Animal models for Parkinson's disease (PD);Animal Models of Alzheimer's disease (AD)
